2-Phenylimidazole

2-Phenylimidazole

SCHEMBL1954238

Br.c1ccc(-c2ncc[nH]2)cc1

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of 2-Phenylimidazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A known ✓ P08913 1/20 0.44
NISCH Q9Y2I1 2/20 0.95
MTOR P42345 1/20 0.95
ADK P55263 1/20 0.95
ALDH1A1 P00352 3/20 0.58
KDM4E B2RXH2 2/20 0.58
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP19A1 P11511 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
PDE3B Q13370 1/20 0.47
PDE3A Q14432 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
CSNK1A1 P48729 2/20 0.44
TYRO3 Q06418 2/20 0.44
DYRK1B Q9Y463 2/20 0.44
VCP P55072 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Phenylimidazole SCHEMBL8901 0.98 NISCH (1.00) NISCHMTORADKALDH1A1KDM4E
2-Phenylimidazole SCHEMBL9719773 0.98 NISCH (1.00) NISCHMTORADKALDH1A1KDM4E
2-Phenylimidazole SCHEMBL5796856 0.95 NISCH (0.95) NISCHMTORADKALDH1A1KDM4E
Biphenyl SCHEMBL7409338 0.95 NISCH (0.95) NISCHMTORADKALDH1A1KDM4E
2-Phenylimidazole SCHEMBL28283863 0.95 NISCH (0.95) NISCHMTORADKALDH1A1KDM4E
2-Phenylimidazole SCHEMBL8898735 0.95 NISCH (0.95) NISCHMTORADKALDH1A1KDM4E
2-Phenylimidazole SCHEMBL1881537 0.95 NISCH (0.95) NISCHMTORADKALDH1A1KDM4E
2-Phenylimidazole SCHEMBL31511436 0.95 NISCH (0.95) NISCHMTORADKALDH1A1KDM4E
2-Phenylimidazole SCHEMBL11072040 0.95 NISCH (0.95) NISCHMTORADKALDH1A1KDM4E
2-Phenylimidazole SCHEMBL28193283 0.95 NISCH (0.95) NISCHMTORADKALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116140857-A Low-temperature soldering paste for reflow soldering and preparation method and application thereof 深圳市汉尔信电子科技有限公司 2023-05-23 CN claimed
US-12605794-B2 Flux and solder paste SENJU METAL INDUSTRY CO., LTD. (JP) 2026-04-21 US disclosed
US-12515281-B2 Flux SENJU METAL INDUSTRY CO., LTD. (JP) 2026-01-06 US disclosed
EP-4332257-B1 FLUX AND SOLDER PASTE SENJU METAL INDUSTRY CO (JP) 2025-10-15 EP disclosed
US-12365054-B2 Flux and solder paste SENJU METAL INDUSTRY CO., LTD. 2025-07-22 US disclosed
US-12304008-B2 Flux and method for producing assembly SENJU METAL INDUSTRY CO., LTD. (JP) 2025-05-20 US disclosed
US-12269806-B2 Flux and solder paste SENJU METAL INDUSTRY CO., LTD. (JP) 2025-04-08 US disclosed
CN-118176084-B Soldering flux and method for producing bonded body 千住金属工业株式会社 2025-03-18 CN disclosed
CN-119585073-A Soldering flux and soldering paste 千住金属工业株式会社 2025-03-07 CN disclosed
CN-118354863-B Method for producing soldering flux and bonded body 千住金属工业株式会社 2025-02-25 CN disclosed
US-20190030656-A1 Flux SENJU METAL INDUSTRY CO., LTD. (JP) 2019-01-31 US disclosed
CN-109071954-A Curable composition, cured film using same, and overcoat film 昭和电工株式会社 2018-12-21 CN disclosed
EP-3409412-A1 FLUX Senju Metal Industry Co., Ltd (JP) 2018-12-05 EP disclosed
CN-108472771-A soldering flux 千住金属工业株式会社 2018-08-31 CN disclosed
CN-102482269-B Proline derivatives NATIONAL HEALTH RESEARCH INSTITUTES (CN) 2015-07-29 CN disclosed
US-8415482-B2 Proline derivatives NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2013-04-09 US disclosed
EP-2507232-A2 PROLINE DERIVATIVES National Health Research Institutes (TW) 2012-10-10 EP disclosed
CN-102482269-A Proline derivatives NAT HEALTH RESEARCH INSTITUTES 2012-05-30 CN disclosed
US-20110136799-A1 PROLINE DERIVATIVES NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2011-06-09 US disclosed
WO-2011068941-A2 PROLINE DERIVATIVES NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2011-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110136799-A1 PROLINE DERIVATIVES PNISR, ARGLU1, PRR12 ADRA2A 4149/4885NISCH 3342/4885MTOR 3282/4885
US-12269806-B2 Flux and solder paste OTC, SLC25A11, PROC ADRA2A 4786/4885NISCH 455/4885MTOR 2691/4885
US-12605794-B2 Flux and solder paste RIOK2, TRA2B, BAG2 ADRA2A 911/4885NISCH 1857/4885MTOR 1109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.